Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/304% above fair value
$29.06+1.75 (+6.41%)
Close on Nov 13, 2026Market cap $4.83BP/E –Yield –
Ionis Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Ionis Pharmaceuticals's EV/EBITDA was 199.7× on Jan 31, 2023, against 31.9× a year earlier. Over the last 4 years it ranged from 14.0× to 764.3×, with a median of 74.9×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 199.7× | +16.2 |
| 2022 | Dec 30, 2022 | 183.5× | +126.9 |
| 2021 | Jan 29, 2021 | 56.6× | +4.4 |
| 2020 | Dec 31, 2020 | 52.1× | −3.4 |
| 2019 | Dec 31, 2019 | 55.5× | −492.9 |
| 2018 | Jul 31, 2018 | 548.4× | +480.2 |
| 2017 | Dec 29, 2017 | 68.2× | −141.8 |
| 2015 | Oct 30, 2015 | 210.0× | – |
See a number that looks wrong?